AU1177397A - Method of diagnosing and treating epithelioma - Google Patents

Method of diagnosing and treating epithelioma

Info

Publication number: AU1177397A
Authority: AU; Australia
Prior art keywords: epithelioma; diagnosing; treating; treating epithelioma
Prior art date: 1995-12-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU11773/97A

Other versions

AU726704B2 (en

Inventor

Gunther Adolf

Karl-Heinz Heider

Elinborg Ostermann

Erik Patzelt

Marlies Sproll

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim International GmbH

Karlsruher Institut fuer Technologie KIT

Original Assignee

Boehringer Ingelheim International GmbH

Forschungszentrum Karlsruhe GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-06

Filing date

1996-12-05

Publication date

1997-06-27

1995-12-06 Priority claimed from DE19545472A external-priority patent/DE19545472A1/en

1996-12-05 Application filed by Boehringer Ingelheim International GmbH, Forschungszentrum Karlsruhe GmbH filed Critical Boehringer Ingelheim International GmbH

1997-06-27 Publication of AU1177397A publication Critical patent/AU1177397A/en

2000-11-16 Application granted granted Critical

2000-11-16 Publication of AU726704B2 publication Critical patent/AU726704B2/en

2016-12-05 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Hematology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Zoology (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Optics & Photonics (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU11773/97A 1995-12-06 1996-12-05 Method of diagnosing and treating epithelioma Ceased AU726704B2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE19545472A DE19545472A1 (en)	1995-12-06	1995-12-06	Diagnosis of squamous epithelial cell carcinoma
DE19545472		1995-12-06
DE19615074		1996-04-17
DE19615074		1996-04-17
PCT/EP1996/005448 WO1997021104A1 (en)	1995-12-06	1996-12-05	Method of diagnosing and treating epithelioma

Publications (2)

Publication Number	Publication Date
AU1177397A true AU1177397A (en)	1997-06-27
AU726704B2 AU726704B2 (en)	2000-11-16

Family

ID=26020988

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU11773/97A Ceased AU726704B2 (en)	1995-12-06	1996-12-05	Method of diagnosing and treating epithelioma

Country Status (26)

Country	Link
EP (1)	EP0865609B1 (en)
JP (1)	JP2000502067A (en)
KR (1)	KR100473824B1 (en)
CN (1)	CN1151377C (en)
AR (1)	AR004360A1 (en)
AT (1)	ATE235056T1 (en)
AU (1)	AU726704B2 (en)
BG (1)	BG62985B1 (en)
BR (1)	BR9611901A (en)
CA (1)	CA2239709A1 (en)
CO (1)	CO4520233A1 (en)
CZ (1)	CZ174198A3 (en)
DE (1)	DE59610248D1 (en)
DK (1)	DK0865609T3 (en)
EE (1)	EE03783B1 (en)
ES (1)	ES2190484T3 (en)
HK (1)	HK1011560A1 (en)
MX (1)	MX9804459A (en)
NO (1)	NO319903B1 (en)
NZ (1)	NZ324314A (en)
PL (1)	PL184521B1 (en)
PT (1)	PT865609E (en)
SK (1)	SK284378B6 (en)
TR (1)	TR199801027T2 (en)
UY (1)	UY24389A1 (en)
WO (1)	WO1997021104A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7189397B2 (en) *	1999-10-08	2007-03-13	Arius Research Inc.	Cytotoxicity mediation of cells evidencing surface expression of CD44
US7947496B2 (en) *	1999-10-08	2011-05-24	Hoffmann-La Roche Inc.	Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) *	1999-10-08	2005-05-12	Young David S.	Cytotoxicity mediation of cells evidencing surface expression of CD44
PE20021098A1 (en) *	2001-05-18	2003-02-11	Boehringer Ingelheim Int	CD44v6 SPECIFIC ANTIBODIES
US20030103985A1 (en)	2001-05-18	2003-06-05	Boehringer Ingelheim International Gmbh	Cytotoxic CD44 antibody immunoconjugates
US6972324B2 (en)	2001-05-18	2005-12-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Antibodies specific for CD44v6
EP1258255A1 (en) *	2001-05-18	2002-11-20	Boehringer Ingelheim International GmbH	Conjugates of an antibody to CD44 and a maytansinoid
EP1391213A1 (en) *	2002-08-21	2004-02-25	Boehringer Ingelheim International GmbH	Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
EP1417974A1 (en) *	2002-11-08	2004-05-12	Boehringer Ingelheim International GmbH	Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
RS53327B (en) *	2010-02-04	2014-10-31	University Of Miami	A monoclonal antibody to cd44 for use in the treatment of head and neck squamous cell carcinoma
US9218450B2 (en) *	2012-11-29	2015-12-22	Roche Molecular Systems, Inc.	Accurate and fast mapping of reads to genome
CN112105643B (en) *	2018-02-22	2023-09-26	普众发现医药科技(上海)有限公司	Therapeutic antibodies and uses thereof
AU2023274919A1 (en)	2022-05-25	2024-12-05	Akiram Therapeutics Ab	Anti-cd44v6 antibodies and their use to treat cd44v6 overexpressing cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU678487B2 (en) *	1993-06-18	1997-05-29	Oy Biotie Therapies Ltd	Compositions and diagnostic methods using monoclonal antibodies against CD44v6
US6010865A (en) *	1993-06-22	2000-01-04	Boehringer Ingelheim International Gmbh	Process for detecting a variant CD44 gene product
DE4326573A1 (en) *	1993-08-07	1995-02-23	Boehringer Ingelheim Int	Polypeptides encoded by exon v5 of the CD44 gene as targets for immunotherapy and immunoscintigraphy of tumors
UA58482C2 (en) *	1994-06-08	2003-08-15	Бьорінгер Інгельхайм Інтернаціональ Гмбх	MONOCLONAL ANTIBODY VFF-18 AGAINST CD44v6 AND ITS FRAGMENTS

1996
- 1996-12-03 UY UY24389A patent/UY24389A1/en not_active IP Right Cessation
- 1996-12-04 AR ARP960105480A patent/AR004360A1/en unknown
- 1996-12-05 PL PL96327066A patent/PL184521B1/en not_active IP Right Cessation
- 1996-12-05 BR BR9611901A patent/BR9611901A/en not_active Application Discontinuation
- 1996-12-05 TR TR1998/01027T patent/TR199801027T2/en unknown
- 1996-12-05 DE DE59610248T patent/DE59610248D1/en not_active Expired - Fee Related
- 1996-12-05 KR KR10-1998-0704242A patent/KR100473824B1/en not_active IP Right Cessation
- 1996-12-05 JP JP9520993A patent/JP2000502067A/en not_active Ceased
- 1996-12-05 PT PT96942362T patent/PT865609E/en unknown
- 1996-12-05 ES ES96942362T patent/ES2190484T3/en not_active Expired - Lifetime
- 1996-12-05 EP EP96942362A patent/EP0865609B1/en not_active Expired - Lifetime
- 1996-12-05 CO CO96063967A patent/CO4520233A1/en unknown
- 1996-12-05 DK DK96942362T patent/DK0865609T3/en active
- 1996-12-05 AT AT96942362T patent/ATE235056T1/en not_active IP Right Cessation
- 1996-12-05 SK SK736-98A patent/SK284378B6/en unknown
- 1996-12-05 NZ NZ324314A patent/NZ324314A/en unknown
- 1996-12-05 CZ CZ981741A patent/CZ174198A3/en unknown
- 1996-12-05 CN CNB961992484A patent/CN1151377C/en not_active Expired - Fee Related
- 1996-12-05 EE EE9800164A patent/EE03783B1/en not_active IP Right Cessation
- 1996-12-05 CA CA002239709A patent/CA2239709A1/en not_active Abandoned
- 1996-12-05 AU AU11773/97A patent/AU726704B2/en not_active Ceased
- 1996-12-05 WO PCT/EP1996/005448 patent/WO1997021104A1/en not_active Application Discontinuation
1998
- 1998-06-04 MX MX9804459A patent/MX9804459A/en not_active IP Right Cessation
- 1998-06-05 BG BG102513A patent/BG62985B1/en unknown
- 1998-06-05 NO NO19982588A patent/NO319903B1/en unknown
- 1998-12-07 HK HK98112910A patent/HK1011560A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG62985B1 (en)	2000-12-29
TR199801027T2 (en)	1998-10-21
EP0865609A1 (en)	1998-09-23
CO4520233A1 (en)	1997-10-15
JP2000502067A (en)	2000-02-22
MX9804459A (en)	1998-09-30
SK73698A3 (en)	1999-01-11
PL327066A1 (en)	1998-11-23
CN1151377C (en)	2004-05-26
AU726704B2 (en)	2000-11-16
ES2190484T3 (en)	2003-08-01
HK1011560A1 (en)	1999-07-16
CZ174198A3 (en)	1999-02-17
BG102513A (en)	1999-02-26
EE03783B1 (en)	2002-06-17
AR004360A1 (en)	1998-11-04
NO982588D0 (en)	1998-06-05
EP0865609B1 (en)	2003-03-19
DK0865609T3 (en)	2003-06-23
BR9611901A (en)	1999-03-02
KR100473824B1 (en)	2005-09-30
WO1997021104A1 (en)	1997-06-12
CN1207811A (en)	1999-02-10
NO982588L (en)	1998-08-05
ATE235056T1 (en)	2003-04-15
UY24389A1 (en)	2001-10-25
NZ324314A (en)	2000-02-28
SK284378B6 (en)	2005-02-04
PL184521B1 (en)	2002-11-29
CA2239709A1 (en)	1997-06-12
DE59610248D1 (en)	2003-04-24
NO319903B1 (en)	2005-09-26
EE9800164A (en)	1998-12-15
PT865609E (en)	2003-08-29
KR19990071952A (en)	1999-09-27

Publication	Publication Date	Title
AU2239997A (en)	1997-07-28	Novel method of diagnosing and treating gliomas
GB2303763B (en)	2000-02-16	Communications system and method of operation
PL326158A1 (en)	1998-08-31	Frame and method of making same
AU2773195A (en)	1996-03-07	Improved wafer and method of making same
GB2301734B (en)	1999-10-20	Communications system and method of operation
AU6584296A (en)	1997-04-10	Well completion system and method
AU7379896A (en)	1997-04-30	Method and apparatus for improving the function of sensory cells
AU5327196A (en)	1996-11-21	Catalyst retaining apparatus and method of making and using same
GB9602819D0 (en)	1996-04-10	Porous-plastic bearing and method of manufacturing porous-plastic bearing
AUPN271295A0 (en)	1995-05-25	Method of treatment
GB2307150B (en)	1999-10-20	An interference reduction scheme and method
PL325401A1 (en)	1998-07-20	Beam and method of making same
AU6527496A (en)	1996-12-24	Anchoring apparatus and method
GB2303240B (en)	1999-06-09	Structure and operation method of LCD
GB2296996B (en)	1999-09-29	Autotransformer and method of operation
AU1177397A (en)	1997-06-27	Method of diagnosing and treating epithelioma
AU1669397A (en)	1997-10-09	Image-forming apparatus and method of manufacturing same
AU1020997A (en)	1997-06-11	Method of treating sepsis
PL325515A1 (en)	1998-08-03	Pultry egg and method of producing same
GB2301749B (en)	1999-07-28	Communications system and method of operation
AU6375396A (en)	1997-02-18	Apparatus and method for stimulation of venous return
PL327603A1 (en)	1998-12-21	Method of aminocarbonylating benzazepins and benzodiazepins
AUPN628895A0 (en)	1995-11-23	Component and method of manufacture thereof
AU7113996A (en)	1997-04-09	Methods of treating beta-amyloid-associated conditions
AU1094597A (en)	1997-06-27	Therapy apparatus and method

Legal Events

Date	Code	Title	Description
2001-03-15	FGA	Letters patent sealed or granted (standard patent)